4,0
23 dic 2022
Dipendente anonimo
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Company with a bright future and a strong pipeline of potentially innovative medicines. Gaining a strong foothold in the US market. Well funded and able to invest in the "next big thing".
Svantaggi
Inexperienced senior management not suited for taking the company to the next level although they are bringing in more seasoned management. Work Life Balance not great although it is improving through localizing much of the work and adding more resources.